Amphastar Pharmaceuticals, Inc. (AMPH) is a publicly traded Healthcare sector company. As of May 21, 2026, AMPH trades at $17.36 with a market cap of $758.40M and a P/E ratio of 10.47. AMPH moved +1.35% today. Year to date, AMPH is -32.34%; over the trailing twelve months it is -27.88%. Its 52-week range spans $16.65 to $53.96. Analyst consensus is neutral with an average price target of $22.00. Rallies surfaces AMPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AMPH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. AMPH recently traded at $17.36. Market cap is $758.40M. P/E ratio is 10.47. Revenue is $720.53M.
| Metric | Value |
|---|---|
| Price | $17.36 |
| Market Cap | $758.40M |
| P/E Ratio | 10.47 |
| EPS | $1.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $53.96 |
| 52-Week Low | $16.65 |
| Volume | 4 |
| Avg Volume | 0 |
| Revenue (TTM) | $720.53M |
| Net Income | $79.23M |
| Gross Margin | 47.34% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $719.89M | $98.09M | $2.10 |
| 2023 | $644.39M | $137.54M | $2.85 |
| 2022 | $498.99M | $91.39M | $1.88 |
| 2021 | $437.77M | $63.30M | $1.30 |
6 analysts cover AMPH: 0 strong buy, 0 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $22.00.